[{"bookmarked": false, "page_rating_contents": 0, "source": "https://brazilian.report/feed/", "page_rating": 0, "user": null, "tags": [], "date_published": "2024-02-02T17:33:34+00:00", "dead": false, "page_rating_visits": 0, "artist": null, "language": "en-US", "title": "Tax cases to take center stage in Supreme Court 2024 term", "source_obj__id": 522, "description": "<p>The post <a href=\"https://brazilian.report/power/2024/02/02/supreme-court-government-tax-cases/\">Tax cases to take center stage in Supreme Court 2024 term</a> appeared first on <a href=\"https://brazilian.report\">The Brazilian Report</a>.</p>", "permanent": false, "comments": [], "vote": 0, "album": "", "link": "https://brazilian.report/power/2024/02/02/supreme-court-government-tax-cases", "page_rating_votes": 0, "thumbnail": null, "age": null}, {"bookmarked": false, "page_rating_contents": 0, "source": "https://brazilian.report/feed/", "page_rating": 0, "user": null, "tags": [], "date_published": "2024-02-02T16:38:06+00:00", "dead": false, "page_rating_visits": 0, "artist": null, "language": "en-US", "title": "S\u00e3o Paulo mayor goes after maligned energy supplier", "source_obj__id": 522, "description": "<p>The post <a href=\"https://brazilian.report/power/2024/02/02/sao-paulo-enel-mayor/\">S\u00e3o Paulo mayor goes after maligned energy supplier</a> appeared first on <a href=\"https://brazilian.report\">The Brazilian Report</a>.</p>", "permanent": false, "comments": [], "vote": 0, "album": "", "link": "https://brazilian.report/power/2024/02/02/sao-paulo-enel-mayor", "page_rating_votes": 0, "thumbnail": null, "age": null}, {"bookmarked": false, "page_rating_contents": 0, "source": "https://brazilian.report/feed/", "page_rating": 0, "user": null, "tags": [], "date_published": "2024-02-02T14:23:50+00:00", "dead": false, "page_rating_visits": 0, "artist": null, "language": "en-US", "title": "Single-dose Brazilian dengue vaccine hits almost 80 percent efficacy", "source_obj__id": 522, "description": "<p>A dengue vaccine being developed by the Butantan Institute, a major research facility owned by the S\u00e3o Paulo state government and the largest vaccine manufacturer in Latin America, had an efficacy of 79.6 percent in clinical trials, according to results published Thursday in The New England Journal of Medicine. Butantan conducted a three-year clinical trial [&#8230;]</p>\n<p>The post <a href=\"https://brazilian.report/liveblog/politics-insider/2024/02/02/brazilian-dengue-vaccine-80-percent-efficacy/\">Single-dose Brazilian dengue vaccine hits almost 80 percent efficacy</a> appeared first on <a href=\"https://brazilian.report\">The Brazilian Report</a>.</p>", "permanent": false, "comments": [], "vote": 0, "album": "", "link": "https://brazilian.report/liveblog/politics-insider/2024/02/02/brazilian-dengue-vaccine-80-percent-efficacy", "page_rating_votes": 0, "thumbnail": null, "age": null}]